{
  "meta": {
    "title": "00073_Mid_Day_Module_Surgery-6",
    "url": "https://brainandscalpel.vercel.app/00073-mid-day-module-surgery-6-2d009b37.html",
    "scrapedAt": "2025-11-29T18:12:33.667Z"
  },
  "questions": [
    {
      "id": 16842,
      "choices": [
        {
          "id": 67328,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cellulitis</span></span></span></span></p>"
        },
        {
          "id": 67329,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stewart Treves syndrome</span></span></span></span></p>"
        },
        {
          "id": 67330,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breast cancer metastasis </span></span></span></span></p>"
        },
        {
          "id": 67331,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seroma formation</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with long-standing lymphedema post modified radical mastectomy (MRM) 2 years ago presented with acute worsening of the lymphedema and the following finding on examination. What is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/picture14.jpg\" style=\"height:276px; width:250px\" /></p>",
      "unique_key": "Q5948551",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621150,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Stewart Treves syndrome</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stewart Treves syndrome&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>lymphangiosarcoma</strong> that develops in <strong>long standing cases of lymphedema post axillary lymph node dissection and irradiation for breast cancer</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It presents as <strong>acute worsening of lymphedema and appearance of bluish-red skin</strong> and <strong>multiple subcutaneous nodules</strong> which can ulcerate and cause hemorrhage.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- pre op chemotherapy and radiation followed by surgical excision, often radical amputation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prognosis is poor.</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Cellulitis. Incorrect</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. While <strong>cellulitis can occur in patients with lymphedema,</strong> the <strong>acute worsening of lymphedema with the appearance of bluish-red skin</strong> and <strong>multiple subcutaneous nodules</strong>, as described in the scenario, is not characteristic of cellulitis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Breast cancer metastasis. Incorrect</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. While <strong>breast cancer metastasis is a possibility</strong>, the presentation described is more suggestive of <strong>Stewart Treves syndrome</strong>, which is a specific complication of lymphedema in breast cancer patients.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Seroma</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>formation</strong> is an <strong>immediate post operative complication</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stewart Treves syndrome</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, is a <strong>rare complication of long-standing lymphedema in breast cancer</strong> patients, characterized by the <strong>development of lymphangiosarcoma in the affected limb</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Sabiston Textbook of Surgery 20th Edition Page 1855.</span></span></strong></span></span></p>",
      "correct_choice_id": 67329,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17370,
      "choices": [
        {
          "id": 69440,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Clean wound- Mastectomy</span></p>"
        },
        {
          "id": 69441,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Clean-contaminated- Breast abscess</span></p>"
        },
        {
          "id": 69442,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Contaminated- Open cardiac massage</span></p>"
        },
        {
          "id": 69443,
          "text": "<p><span style=\"font-size:12pt;\">Dirty- Fournier’s gangrene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the mismatch type of surgical wound?</span></p>",
      "unique_key": "Q9426069",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621151,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Clean-contaminated- Breast abscess</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Pus in wound is a dirty wound.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Class II Clean:</strong>&nbsp; <strong>Uninfected operative wounds</strong>, <strong>no inflammation</strong> is encountered. Respiratory, alimentary, genital, or uninfected urinary tracts are not entered. <strong>Primarily closed</strong> and, if necessary, drained using a closed system</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Class III Clean contaminated</strong>: Respiratory, alimentary, genital, or urinary tracts are entered <strong>under controlled conditions and without unusual contamination</strong>. No evidence of infection or major break in technique is encountered.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Class IIII Contaminated:&nbsp;</strong>Open, <strong>fresh accidental wounds</strong>. Operation in which there is <strong>major breaks in sterile technique (e.g., open cardiac massage) or gross spillage from the gastrointestinal tract</strong>. Incisions in which acute, non-purulent inflammation is encountered.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Class IVI Dirty:&nbsp;</strong>Old traumatic wounds with retained devitalised tissue, and those that involve <strong>existing clinical infection (pus) or perforated viscera</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective</u></strong><u> :</u></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Breast abscess contains pus. Pus in wound is a dirty wound and not clean- contaminated.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>:&nbsp;Bailey 28<sup>th</sup> Ed. Pg 28.</strong></span></p>",
      "correct_choice_id": 69441,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57105,
      "choices": [
        {
          "id": 227809,
          "text": "<p><span style=\"font-size:12.0pt;\">Simple mastectomy</span></p>"
        },
        {
          "id": 227810,
          "text": "<p><span style=\"font-size:12.0pt;\">MRM (Modified Radical Mastectomy)</span></p>"
        },
        {
          "id": 227811,
          "text": "<p><span style=\"font-size:12.0pt;\">Radical mastectomy</span></p>"
        },
        {
          "id": 227812,
          "text": "<p><span style=\"font-size:12.0pt;\">Neoadjuvant chemotherapy followed by surgery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Image of a patient with large ulcerated breast cancer with liver metastasis. What is the management? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-115837.jpg\" alt=\"\" width=\"450\" height=\"408\"></span></p><p>&nbsp;</p>",
      "unique_key": "Q8022234",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621152,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Simple mastectomy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient in the image has a large ulcerated breast tumor with confirmed liver metastasis, classifying the cancer as stage IV (T4, M1). In cases of stage IV breast cancer with distant metastasis, the primary goal of management shifts from curative to palliative care, focusing on improving quality of life and managing symptoms.</span></p><p><span style=\"font-size:12.0pt;\">For patients with large ulcerated tumors, palliative simple mastectomy may be considered to alleviate symptoms like pain, ulceration, discharge, or infection, which can significantly impact the patient’s quality of life. This procedure is not intended to cure but to provide local control of the tumor and improve comfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. MRM (Modified Radical Mastectomy):</strong> This is a more aggressive surgical approach that involves removal of the breast tissue along with axillary lymph nodes. It is typically reserved for curative intent in earlier stages of breast cancer without distant metastasis. It is not appropriate for palliation in stage IV disease with liver metastasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Radical mastectomy:</strong> This involves removal of the entire breast, underlying chest muscles, and axillary lymph nodes. This extensive procedure is rarely performed today and is not suitable for palliative care in metastatic disease due to its high morbidity without a survival benefit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Neoadjuvant chemotherapy followed by surgery:</strong> Neoadjuvant chemotherapy is used in locally advanced breast cancer (LABC) to shrink tumors before surgery, but in the presence of distant metastasis (M1), systemic chemotherapy alone would be preferred for palliative purposes. Surgery would only follow if there was a significant symptomatic tumor burden requiring local control.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with stage IV breast cancer with distant metastasis, such as liver metastasis, the primary focus is on palliation. Simple mastectomy may be performed to manage symptoms from a large ulcerated tumor, but more extensive surgeries or curative approaches are not indicated.</span></p>",
      "correct_choice_id": 227809,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56748,
      "choices": [
        {
          "id": 226393,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seroma</span></span></p>"
        },
        {
          "id": 226394,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphoedema</span></span></p>"
        },
        {
          "id": 226395,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wound infection</span></span></p>"
        },
        {
          "id": 226396,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intercostobrachial nerve injury</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 48-year-old woman underwent a modified radical mastectomy for breast cancer. A few days after the surgery, she presents with swelling and a fluid collection beneath the skin flaps in her axillary region. Which of the following is the most common complication following mastectomy surgery?</span></span></p>",
      "unique_key": "Q8880459",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621153,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Seroma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A <strong>seroma</strong> is the accumulation of fluid beneath the skin flaps after surgery, particularly in the axilla following mastectomy and axillary lymph node dissection. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is the <strong>most common complication</strong> of mastectomy, occurring in approximately 30% of cases. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Seromas can lead to discomfort, delayed wound healing, and an increased risk of infection if not adequately drained.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Lymphoedema:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Lymphoedema is swelling that occurs due to the disruption of lymphatic drainage, which can happen after axillary lymph node dissection. While it is a well-known complication of mastectomy, it is <strong>less common</strong> than seroma formation in the immediate postoperative period.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Wound infection:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Wound infections can occur after any surgical procedure, including mastectomy. However, the <strong>incidence of seroma formation</strong> is higher than that of wound infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Intercostobrachial nerve injury:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Injury to the intercostobrachial nerve, leading to numbness or paresthesia in the upper arm, is a recognized complication of mastectomy, but it is less common compared to seroma formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seroma</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the most common complication following mastectomy, occurring in approximately <strong>30%</strong> of cases and requires management to prevent infection and promote healing.</span></span></li>\r\n</ul>",
      "correct_choice_id": 226393,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47986,
      "choices": [
        {
          "id": 191539,
          "text": "<p>Apical nodes</p>"
        },
        {
          "id": 191540,
          "text": "<p>Anterior (pectoral) nodes</p>"
        },
        {
          "id": 191541,
          "text": "<p>Parasternal (internal thoracic) nodes</p>"
        },
        {
          "id": 191542,
          "text": "<p>Supraclavicular nodes</p>"
        }
      ],
      "text": "<p>Lymph from a cancerous breast primarily drains into which of the following nodes? (NEET PG 2017)</p>",
      "unique_key": "Q3337064",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621154,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><strong>Correct Answer. B. Anterior (pectoral) nodes</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong>&nbsp;</p><p>&nbsp;</p><p>The lymphatic drainage of the breast primarily flows into the anterior (pectoral) group of axillary lymph nodes. These nodes are positioned along the lateral thoracic vessels at the lower border of the pectoralis minor muscle. Approximately 75% of the lymph from the breast tissue drains into the axillary nodes, with the anterior group receiving the major portion. This makes the anterior (pectoral) nodes the first-line lymph nodes to receive drainage from cancerous breast tissue, particularly from the upper lateral quadrant where breast cancer most commonly occurs.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><ul><li><strong>Option&nbsp;A. Apical nodes</strong>: Located at the apex of the axilla, these nodes receive lymph secondarily after it has passed through other axillary node groups. They're not the primary recipients of breast lymph drainage.</li><li><strong>Option&nbsp;C. Parasternal (internal thoracic) nodes</strong>: These nodes receive about 20% of breast lymphatic drainage, primarily from the medial quadrants of the breast, but are not the main drainage pathway.</li><li><strong>Option&nbsp;D. Supraclavicular nodes</strong>: These become involved primarily in advanced cases of breast cancer. They receive lymph only after it has passed through multiple other node groups.</li></ul><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Anterior (pectoral) lymph nodes are the primary recipients of lymphatic drainage from the breast, making them crucial for early detection and staging of breast malignancy.</p>",
      "correct_choice_id": 191540,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66265,
      "choices": [
        {
          "id": 264205,
          "text": "<p><span style=\"font-size:14.0pt;\">A-3, B-2, C-4, D-1</span></p>"
        },
        {
          "id": 264206,
          "text": "<p><span style=\"font-size:14.0pt;\">A-1, B-4, C-3, D-2</span></p>"
        },
        {
          "id": 264207,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-3, C-4, D-1</span></p>"
        },
        {
          "id": 264208,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-3, C-1, D-4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following staging/grading systems with their respective cancers:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Staging Systems:</strong></span></p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">Gleason grading</span></li><li><span style=\"font-size:14.0pt;\">Duke staging</span></li><li><span style=\"font-size:14.0pt;\">Robson staging</span></li><li><span style=\"font-size:14.0pt;\">Bloom-Richardson grading</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cancers:</strong></span></p><ol><li><span style=\"font-size:14.0pt;\">Renal cell carcinoma (RCC)</span></li><li><span style=\"font-size:14.0pt;\">Prostate cancer</span></li><li><span style=\"font-size:14.0pt;\">Colorectal carcinoma</span></li><li><span style=\"font-size:14.0pt;\">Breast cancer</span></li></ol>",
      "unique_key": "Q2243223",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621155,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) A-2, B-3, C-1, D-4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A. Gleason staging – 2. Prostate cancer</strong>: This system is used to grade prostate cancer based on histological patterns.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B. Duke staging – 3. Colorectal carcinoma</strong>: Duke staging is a classic system used to classify colorectal cancer based on the depth of invasion and lymph node involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C. Robson staging – 1. Renal cell carcinoma (RCC)</strong>: Robson's system is a staging classification for RCC based on tumor extent and spread.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D. Bloom-Richardson grading – 4. Breast cancer</strong>: This system is used to grade breast carcinoma based on histological characteristics such as mitotic count, nuclear grade, and tubule formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Different cancers have unique staging and grading systems tailored to their anatomical and pathological characteristics. Familiarity with these systems is essential for diagnosis, treatment planning, and prognosis.</span></li></ul>",
      "correct_choice_id": 264208,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14408,
      "choices": [
        {
          "id": 57593,
          "text": "<p><span style=\"font-size:12.0pt;\">Tumor more than 4 cm</span></p>"
        },
        {
          "id": 57594,
          "text": "<p><span style=\"font-size:12.0pt;\">Inflammatory breast cancer</span></p>"
        },
        {
          "id": 57595,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest wall involvement</span></p>"
        },
        {
          "id": 57596,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin involvement</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Locally advanced breast cancer can be defined as all except? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q2773399",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621156,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tumor more than 4 cm</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While a tumor size larger than 4 cm is indicative of a relatively large tumor, it alone does not define locally advanced breast cancer. Locally advanced breast cancer typically involves not only tumor size but also the extent of its spread to nearby structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Inflammatory breast cancer</strong>:<strong> </strong>Inflammatory breast cancer is an aggressive subtype of breast cancer characterized by redness, swelling, and warmth in the breast. It is considered an advanced stage of breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chest wall involvement</strong>:<strong> </strong>Locally advanced breast cancer is often defined by its involvement of the chest wall. This means that the cancer has spread beyond the breast tissue and may affect the underlying muscles and structures of the chest wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. Skin involvement</strong>: Skin involvement, such as changes in the appearance of the skin over the breast like peau’d orange or ulceration, can be a feature of locally advanced breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tumor more than 5 cm, not 4 is classified as LABC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Locally advanced breast cancer (LABC) includes: (Mnemonic – CUBE N2)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">C - Chest wall invasion</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">U - Ulceration of skin</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">B - Both (chest wall invasion and ulceration of skin)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">E - E(I)nflammatory carcinoma</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">N2 - fixed axillary lymph nodes</span></p>",
      "correct_choice_id": 57593,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14438,
      "choices": [
        {
          "id": 57713,
          "text": "<p><span style=\"font-size:12pt;\">Estrogen</span></p>"
        },
        {
          "id": 57714,
          "text": "<p><span style=\"font-size:12pt;\">Clomiphene citrate</span></p>"
        },
        {
          "id": 57715,
          "text": "<p><span style=\"font-size:12pt;\">Tamoxifen</span></p>"
        },
        {
          "id": 57716,
          "text": "<p><span style=\"font-size:12pt;\">Adriamycin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mrs. Patel is a 45-year-old woman who has recently been diagnosed with estrogen receptor-positive breast cancer. Her doctor informs her that the cancer is hormone-dependent. The doctor recommends a treatment plan that includes surgery, radiation therapy, and hormone therapy. What is the drug used for estrogen dependent breast cancer? (NEET PG 2019)</span></p>",
      "unique_key": "Q6900904",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621157,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Tamoxifen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tamoxifen is a selective estrogen receptor modulator (SERM) used to treat hormone receptor-positive breast cancers, particularly in premenopausal women. It is effective for estrogen receptor-positive breast cancer, which is hormone-dependent. Tamoxifen works by blocking the effects of estrogen in the breast tissue, thereby preventing cancer cells from growing and spreading.</span></p><ul><li><span style=\"font-size:12pt;\"><strong>Mechanism of Action</strong>: Tamoxifen competes with estrogen for binding to estrogen receptors in breast tissue. By blocking estrogen's effects, it inhibits the growth and proliferation of estrogen-dependent cancer cells.</span></li><li><span style=\"font-size:12pt;\"><strong>Administration</strong>: Tamoxifen is taken orally, usually once a day for five years.</span></li><li><span style=\"font-size:12pt;\"><strong>Side Effects</strong>: Common side effects include hot flashes, mood changes, vaginal dryness, and an increased risk of blood clots (DVT).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Uses of Tamoxifen</strong>:</span></p><ul><li><span style=\"font-size:12pt;\"><strong>Primary Prophylaxis</strong>: Used for the primary prophylaxis of breast cancer in high-risk women.</span></li><li><span style=\"font-size:12pt;\"><strong>Risk Reduction</strong>: Reduces the risk of carcinoma in the contralateral breast.</span></li><li><span style=\"font-size:12pt;\"><strong>Recurrence Prevention</strong>: Lowers the risk of recurrence of carcinoma in both ipsilateral and contralateral breasts.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Estrogen:&nbsp;</strong>Estrogen is not used as a treatment for estrogen receptor-positive breast cancer because it would promote cancer cell growth. In fact, therapies aim to reduce or block estrogen to prevent cancer progression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Clomiphene citrate:&nbsp;</strong>Clomiphene citrate is a medication used to induce ovulation in women with fertility issues. It is not used in the treatment of breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Adriamycin (Doxorubicin):&nbsp;</strong>Adriamycin is a chemotherapy drug used to treat various types of cancer, including breast cancer. It works by interfering with the DNA in cancer cells, preventing them from dividing and growing. While effective in some cancer treatments, it is not specifically used for hormone therapy in estrogen receptor-positive breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tamoxifen is the drug used for treating estrogen receptor-positive breast cancer by blocking the effects of estrogen on breast tissue, thereby preventing the growth and spread of hormone-dependent cancer cells.</span></p>",
      "correct_choice_id": 57715,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44276,
      "choices": [
        {
          "id": 176755,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Located on the long arm of chromosome 13</span></span></p>"
        },
        {
          "id": 176756,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Well-differentiated tumors</span></span></p>"
        },
        {
          "id": 176757,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ER/PR-positive hormone receptor status</span></span></p>"
        },
        {
          "id": 176758,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Associated with medullary carcinoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with a family history of breast cancer is found to have a BRCA1 mutation. Which of the following characteristics is associated with a BRCA1 mutation compared to a BRCA2 mutation?</span></span></p>",
      "unique_key": "Q5264030",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621158,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D) Associated with medullary carcinoma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">BRCA1 mutations are located on the long arm of chromosome 17 and are associated with poorly differentiated tumors and a triple-negative hormone receptor status (ER/PR-negative, HER2-negative). </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They are also linked to medullary carcinoma. BRCA2 mutations are located on chromosome 13.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A. Located on the long arm of chromosome 13:</strong> BRCA2 mutations are located on chromosome 13. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Well-differentiated tumors:</span></strong><span style=\"font-size:14.0pt\"> BRCA1 mutations are associated with poorly-differentiated tumors. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C. ER/PR-positive hormone receptor status:</strong> BRCA1 mutations are ER/PR negative.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">BRCA1 mutations are linked to chromosome 17, poorly differentiated tumors, triple-negative status, and medullary carcinoma, while BRCA2 mutations are linked to chromosome 13.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 176758,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61234,
      "choices": [
        {
          "id": 244217,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thoracodorsal nerve</span></span></span></p>"
        },
        {
          "id": 244218,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Long thoracic nerve</span></span></span></p>"
        },
        {
          "id": 244219,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Spinal accessory nerve</span></span></span></p>"
        },
        {
          "id": 244220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dorsal scapular nerve</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman undergoes a modified radical mastectomy (MRM) for breast cancer. During the surgery, the surgeon identifies and carefully preserves the nerve marked in the image. Which nerve is being identified in the image? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162630.png\" style=\"height:207px; width:300px\" /></p>",
      "unique_key": "Q1912307",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621159,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Long thoracic nerve</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This nerve innervates the serratus anterior muscle and is important for scapular protraction and stabilization. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Damage to the long thoracic nerve can result in a &quot;winged scapula.&quot;</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Thoracodorsal nerve</span></strong><span style=\"font-size:14.0pt\">: The thoracodorsal nerve, also known as the nerve to latissimus dorsi, is responsible for innervating the latissimus dorsi muscle. This muscle plays a key role in shoulder adduction, extension, and internal rotation. The thoracodorsal nerve arises from the posterior cord of the brachial plexus and runs along the axillary region, which is commonly encountered and preserved during surgeries such as a modified radical mastectomy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Spinal accessory nerve:</span></strong><span style=\"font-size:14.0pt\"> This nerve innervates the trapezius and sternocleidomastoid muscles. It is often involved in shoulder elevation and neck movements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Dorsal scapular nerve</span></strong><span style=\"font-size:14.0pt\">: This nerve innervates the rhomboid muscles and the levator scapulae, which are involved in the retraction and elevation of the scapula.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/whatsapp-image-2024-10-16-at-113725-am.jpeg\" style=\"height:383px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Long thoracic nerve innervates the serratus anterior muscle and is important for scapular protraction and stabilization. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Damage to the long thoracic nerve can result in a &quot;winged scapula.&quot;</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244218,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11462,
      "choices": [
        {
          "id": 45814,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcohol </span></span></span></p>"
        },
        {
          "id": 45815,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early age of first live childbirth</span></span></span></p>"
        },
        {
          "id": 45816,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early menarche </span></span></span></p>"
        },
        {
          "id": 45817,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which out of these is not a risk factor for breast carcinoma?</span></span></span></p>",
      "unique_key": "Q4817063",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621160,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Early age of first live child birth.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early age of first live childbirth&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">an <strong>early age at first full-term pregnancy</strong> is generally considered a <strong>protective factor against breast cancer.</strong> This <strong>protection</strong> may be due to <strong>hormonal changes</strong> that occur during pregnancy that have a long-term effect on the cells in the breast. <strong>Having the first child after 35 years of age (late parity) is a risk factor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A: Alcohol.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alcohol consumption</strong> is a well-established <strong>risk factor for the development of breast cancer</strong>. The risk increases with the amount of alcohol consumed, and this association is thought to be due to alcohol&#39;s effects on estrogen and other hormonal levels, as well as its ability to damage DNA in cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Early menarche.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Early onset of menstruation</strong> (menarche) is a <strong>risk factor for breast cancer</strong>. The earlier a woman begins menstruating, the longer her breast tissue is exposed to estrogen, which can promote the growth of cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Nulliparity.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity, or <strong>never having given birth to a child</strong>, is also a recognized <strong>risk factor for breast cancer</strong>. This is thought to be due to the absence of the protective hormonal changes that occur during pregnancy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Protective factors for carcinoma breast:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early age at first pregnancy</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiparity</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breastfeeding</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oophorectomy</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exercise </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamoxifen and aromatase inhibitors</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk factors for breast carcinoma:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age: incidence increases with increasing age.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sex: more common in females.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Personal history and family history of breast cancer</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Race, ethnicity (white women have increased risk compared to women of other races)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">History of radiation exposure</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mammographically dense breast </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genetic factors:</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutations in tumor suppressor genes</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA 1</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA 2</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TP53</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CHEK2</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditary syndromes</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Li Fraumeni syndrome</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cowden&rsquo;s syndrome</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HNPCC syndrome</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peutz - Jeghers syndrome</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ataxia telangiectasia </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormonal factors (hypercarotenemia is the risk factor)</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early menarche (&lt;12 years)</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Late gmenopause (&gt; 55 years)</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">First full-term pregnancy &gt;35 years</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obesity (Postmenopausal)</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Higher socioeconomic status, high fat diet, alcohol intake, chest wall radiation</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OCPills and smoking have a low risk association</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bailey &amp; love&rsquo;s short practice of surgery -28<sup>th</sup> edition page no 931, table 58.3</span></strong></span></span></p>",
      "correct_choice_id": 45815,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11463,
      "choices": [
        {
          "id": 45818,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apocrine metaplasia </span></span></span></p>"
        },
        {
          "id": 45819,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Florid hyperplasia </span></span></span></p>"
        },
        {
          "id": 45820,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atypical hyperplasia </span></span></span></p>"
        },
        {
          "id": 45821,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LCIS</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a pre malignant lesion associated with breast cancer?</span></span></span></p>",
      "unique_key": "Q1033182",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621161,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Apocrine metaplasia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apocrine metaplasia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is seen in <strong>breast cysts</strong> and is <strong>always benign.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apocrine Metaplasia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>benign change</strong> in the <strong>breast</strong> where <strong>ductal epithelial cells transform into cells resembling those of the apocrine glands</strong>. It is often <strong>found in fibrocystic</strong> changes and is not associated with an increased risk of developing breast cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Florid Hyperplasia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Florid hyperplasia, also known as <strong>usual ductal hyperplasia,</strong> is an <strong>overgrowth of the cells lining the ducts of the breast tissue</strong>. While it is not in itself considered premalignant, there is a slight increase in the risk of developing breast cancer compared to the general population, particularly when the hyperplasia is moderate to florid.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Atypical Hyperplasia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atypical hyperplasia is a condition <strong>where there is an overgrowth of cells in the breast with some atypical</strong> (abnormal) <strong>appearance</strong>. This includes both atypical ductal hyperplasia (ADH) and atypical lobular hyperplasia (ALH). It is a recognized premalignant lesion and is associated with a higher risk of developing breast cancer &mdash; approximately four to five times the risk compared to women without these lesions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: LCIS&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lobular Carcinoma in Situ (LCIS) is a condition in which <strong>abnormal cells are found in the lobules of the breast.</strong> This is considered a marker for an increased risk of developing breast cancer in either breast and is therefore often categorized as a premalignant lesion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apocrine metaplasia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Option A) is <strong>not a premalignant lesion</strong> associated with <strong>breast cancer</strong>; it is a <strong>benign finding commonly seen in breast cysts</strong> and does not confer an <strong>increased risk for developing breast cancer</strong>. Conversely, conditions like <strong>florid hyperplasia, atypical hyperplasia</strong>, and <strong>LCIS</strong> are associated with a <strong>higher risk</strong> and are considered premalignant to varying degrees.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No increased risk</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenosis, sclerosing or florid</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apocrine metaplasia </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cysts, macro and / or micro</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Duct ectasia</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fibroadenoma</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fibrosis</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperplasia</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mastitis (inflammation)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Periductal mastitis</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Slightly increased risk (1.5-2 times)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperplasia, moderate or florid, solid, or papillary </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papilloma with a fibrovascular core (relative risk =3)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Moderately increased risk (5 times)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atypical hyperplasia (ductal or lobular) (Relative risk = 4 or 5)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insufficient data to assign a risk</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Solitary papilloma of lactiferous sinus</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radial scar lesion</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/screenshot-2024-03-20-171352.png\" style=\"height:187px; width:800px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bailey &amp; love&rsquo;s short practice of surgery -27<sup>th</sup> edition page no 871</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">28<sup>th</sup> Ed. Table 58.3</span></strong></span></span></p>",
      "correct_choice_id": 45818,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11464,
      "choices": [
        {
          "id": 45822,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA1 is associated with 50 to 85% lifetime risk of Ca Breast. </span></span></span></p>"
        },
        {
          "id": 45823,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA2 is located in chromosome 13. </span></span></span></p>"
        },
        {
          "id": 45824,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA1 is mostly associated with triple receptor-negative cancers. </span></span></span></p>"
        },
        {
          "id": 45825,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA1 is highly associated with male breast carcinoma.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about BRCA genes is incorrect?</span></span></p>",
      "unique_key": "Q6233524",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621162,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) BRCA1 is highly associated with male breast carcinoma. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA1 is highly associated with male breast carcinoma.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>not correct</strong>. <strong>While mutations in both BRCA1 and BRCA2 can increase</strong> the risk of <strong>male breast cancer</strong>, <strong>BRCA2</strong> mutations are more <strong>commonly associated with breast cancer</strong> in men than BRCA1 mutations.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Comparison between BRCA 1 and BRCA 2:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both BRCA1 and BRCA2 are tumor suppressor genes with Autosomal dominant inheritance.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma breast occurs at an earlier age and is bilateral and multicentric inherited form compared to sporadic cases.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: BRCA1 is associated with a 50 to 85% lifetime risk of Ca Breast.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>correct</strong>. Women with mutations in the BRCA1 gene have a significantly increased risk of developing breast cancer, with lifetime risks ranging from 50% to 85%.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: BRCA2 is located on chromosome 13.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>correct</strong>. The BRCA2 gene is indeed located on chromosome 13q.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: BRCA1 is mostly associated with triple receptor-negative cancers.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>correct</strong>. BRCA1 mutations are often associated with breast cancers that are triple-negative, meaning they lack estrogen receptors, progesterone receptors, and HER2/neu expression.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/screenshot-2024-03-20-171906.png\" style=\"height:446px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Schwartz&rsquo;s principle of surgery-10<sup>th</sup> edition page no 515</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Devita-cancer principle and practice of oncology; 10<sup>th</sup> edition page no 1109</span></strong></span></span></p>",
      "correct_choice_id": 45825,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11466,
      "choices": [
        {
          "id": 45830,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infiltration of Cooper&rsquo;s ligaments</span></span></span></p>"
        },
        {
          "id": 45831,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obstruction of subcutaneous lymphatics</span></span></span></p>"
        },
        {
          "id": 45832,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infiltration of lactiferous duct</span></span></span></p>"
        },
        {
          "id": 45833,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infiltration of subcutaneous veins</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman presents with rapidly progressive breast lump with skin changes as shown. What is the likely pathology responsible for this finding?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/screenshot-2024-03-20-172458.png\" style=\"height:288px; width:300px\" /></span></span></p>",
      "unique_key": "Q6123732",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621163,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Obstruction of subcutaneous lymphatics</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The characteristic <strong>Peau d&#39;orange appearance in breast carcinoma is due to specific pathological changes associated with dermal subcutaneous lymphatics obstruction</strong>, typically by <strong>cancer cells</strong>, leading to <strong>lymphatic edema</strong>. This edema causes the skin to take on a texture reminiscent of an orange peel, with enlarged pores and thickened skin</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Infiltration of Lactiferous Duct&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While the infiltration of lactiferous ducts can <strong>lead to nipple retraction or inversion</strong>, it is <strong>not the cause of Peau d&#39;orange</strong>. Nipple retraction occurs because the ducts shorten as they are invaded by cancer cells, which pulls the nipple inward.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peau d&#39;orange in breast carcinoma&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is specifically <strong>caused by the obstruction of subcutaneous lymphatics,</strong> leading to <strong>lymphatic edema</strong> and the <strong>characteristic orange peel-like texture of the skin</strong>, an indicator of advanced disease (T4b).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peau D&#39;orange&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is caused by <strong>cutaneous lymphatic edema</strong> due to the <strong>obstruction of subcutaneous lymphatics</strong>. It is French for &ldquo;<strong>orange skin</strong>&rdquo;.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other appearances due to local invasion are as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infiltration of single cooper&#39;s ligaments leads to dimpling of skin while multiple ligaments leads to puckering/wrinkling. Simple maneuvers such as stretching the arms high above the head or tensing the pectoralis muscles may accentuate asymmetries and dimpling.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infiltration of the lactiferous ducts leads to nipple retraction. Note: an inverted nipple can be simply pulled out, however a retracted nipple cannot be pulled out.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cancer-en-cuirasse: in this condition, the skin of the chest is infiltrated with carcinoma and its appearance has been compared to that of a coat. It occurs in local recurrence after mastectomy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peau D&#39;orange indicates skin involvement (T4b)&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in breast carcinoma.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dimpling of the skin and nipple retraction do not indicate skin involvement.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/picture1.png\" style=\"height:196px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bailey &amp; love&rsquo;s short practice of surgery -28<sup>th</sup> edition page 932, Schwartz&rsquo;s principles of surgery- 10<sup>th</sup> edition page no 518, Sabiston textbook of surgery 20<sup>th</sup> edition page no 849</span></strong></span></span></p>",
      "correct_choice_id": 45831,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11469,
      "choices": [
        {
          "id": 45842,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRM in node negative patients</span></span></span></p>"
        },
        {
          "id": 45843,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRM in node positive patients</span></span></span></p>"
        },
        {
          "id": 45844,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BCT in node negative patients</span></span></span></p>"
        },
        {
          "id": 45845,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BCT in node positive patients</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In which of the given cases is this procedure usually performed?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/picture1_bjxNn3P.png\" style=\"height:202px; width:300px\" /></span></span></p>",
      "unique_key": "Q1337056",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621164,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) BCT in node negative patients</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following image shows a <strong>sentinel lymph node biopsy using a gamma camera</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BCT in Node-Negative Patients</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Breast-conserving therapy&nbsp;</strong>(BCT) in <strong>node-negative patients</strong> is the typical indication for<strong> SLNB.</strong> The procedure is <strong>used to assess whether breast cancer has spread to the sentinel node</strong>, which is the <strong>first lymph node to which cancer cells are likely to spread from the primary tumor</strong>. If the sentinel node is free of cancer, it suggests that the other nodes are also likely to be cancer-free, potentially obviating the need for full axillary lymph node dissection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A and B: MRM:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Axillary lymph node dissection</strong> is usually <strong>performed as part of the surgical treatment</strong> rather than SLNB in all cases of MRM.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: BCT in Node-Positive Patients&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In node-positive patients, <strong>BCT would include an axillary lymph node dissection to address the known nodal involvement</strong>, rather than just an SLNB, because the presence of cancer cells in the lymph nodes is already confirmed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sentinel lymph node biopsy&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is most commonly performed as part of <strong>breast-conserving therapy</strong> in patients with <strong>no clinical evidence of lymph node involvement</strong> (node-negative) to determine the <strong>presence of metastatic cancer cells</strong> in the <strong>sentinel lymph node</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sentinel lymph node biopsy:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">First performed by Dr. Cabana for penile carcinoma</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sentinel lymph node is the first draining lymph node</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only done on node-negative tumors as a part of BCS/BCT. In node positive patients, BCT includes axillary lymph node clearance directly (without SLNB).</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In MRM, axillary clearance is done irrespective of clinical nodal status.</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Technique: methylene blue dye or radioisotope (technetium)-labeled albumin is injected into breast tissue (or subdermal tissue) at the site of the primary tumor or at the subareolar position. The sentinel node is identified as a blue node or as a radioactive node (using a gamma camera).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The frozen section biopsy is sent to the pathologist for identification of cancer cells. If the biopsy is positive for cancer cells, then axillary dissection is simultaneously performed.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The combination of blue dye and technetium-labeled colloid has been reported to improve the detection of sentinel lymph nodes.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Newer techniques involve the use of a fluorescent or magnetic tracer instead of the radiolabeled dye.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bailey &amp; love&rsquo;s practice of surgery -28<sup>th</sup> edition page no 936-37.</span></strong></span></span></p>",
      "correct_choice_id": 45844,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11473,
      "choices": [
        {
          "id": 45858,
          "text": "<p style=\"margin-left:6px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T3</span></span></span></p>"
        },
        {
          "id": 45859,
          "text": "<p style=\"margin-left:6px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T4a</span></span></span></p>"
        },
        {
          "id": 45860,
          "text": "<p style=\"margin-left:6px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T4b</span></span></span></p>"
        },
        {
          "id": 45861,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T4c</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman presents with a breast tumor of size 6 x 3cm, with adherence to the pectoralis major muscle. Overlying skin shows dimpling. As her surgeon, what will you designate her T staging as?</span></span></p>",
      "unique_key": "Q5602129",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621165,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) T3</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>tumor is of size 6cm</strong>. Hence it is stage <strong>T3 (&gt;5cm).</strong> <strong>Fixity to pectoralis major doesn&rsquo;t affect staging</strong>. Skin dimpling is <strong>not</strong> classified as T4b.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Irrelevant to the size of the tumor</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, if the <strong>tumor shows extension to the chest wall or skin</strong>, it is classified as <strong>T4</strong>. However, there are two exceptions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Invasion or adherence to pectoralis muscle in the absence of chest wall involvement does not qualify as T4.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Similarly, involvement of the dermis in the form of dimpling/puckering/retraction of nipple does not qualify as T4.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Points to Remember</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In tumor size assessment, the greatest dimension is taken into consideration. For example, in a 6*3 cm lump, 6 cm is taken into account, and the tumor is classified as T3(&gt;5 cm).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skin involvement does not include nipple retraction and skin dimpling.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Supraclavicular lymph node involvement indicates N3c.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Any contralateral lymph node involvement is considered as distant metastasis.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If 2 lumps are present in the same breast, staging is according to the bigger lump.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If lumps are present in both breasts, separate staging is done for both the lumps.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TNM Staging of carcinoma breast.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/screenshot-2024-03-20-173615.png\" style=\"height:878px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/screenshot-2024-03-20-173816.png\" style=\"height:601px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">#Chest wall includes serratus anterior, intercostal muscles, ribs. Pectoralis muscle is not a part of the chest wall.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">*Inflammatory breast carcinoma (stage IIIB) is characterized by the skin changes of brawny induration, erythema with a raised edge, and edema (peau d&#39;orange) involving &ge; 1/3<sup>rd</sup> of breast.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note: LCIS (lobular carcinoma in situ) is considered as a benign condition and not included under Tis.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Sabiston textbook of surgery 20<sup>th</sup> edition page no 843 and 844, Schwartz&rsquo;s principle of surgery -10<sup>th</sup> edition page no 532, Journal AJCC-2017, Pg 674.</span></strong></span></span></p>",
      "correct_choice_id": 45858,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11476,
      "choices": [
        {
          "id": 45870,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T2 N2a M0</span></span></span></p>"
        },
        {
          "id": 45871,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T4b N3c M0</span></span></span></p>"
        },
        {
          "id": 45872,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T2 N3c M1</span></span></span></p>"
        },
        {
          "id": 45873,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T4b N3c M1</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient present with a left breast lump of size 3cm x 4cm. The overlying skin has a &lsquo;orange-like skin&rsquo; appearance. On the right side, mobile axillary nodes are palpable. On the left side, supraclavicular lymph nodes are palpable. The most appropriate tumor staging is:</span></span></p>",
      "unique_key": "Q8918584",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621166,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) T4b N3c M1</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the <strong>TNM staging system for breast cancer</strong>, <strong>T</strong> refers to the <strong>size and extent of the main tumor</strong>, <strong>N</strong> describes the <strong>absence or presence and extent of regional lymph node involvement</strong>, and <strong>M</strong> indicates the <strong>absence or presence of distant metastases.</strong> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumor of any size with overlying skin involvement</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (Peau d&#39;orange appearance): T4b</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipsilateral supraclavicular lymph node involvement</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: N3c</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Involvement of any contralateral lymph nodes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> indicates metastasis in the case of breast carcinoma: M1</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therefore, the staging is <strong>T4b N3c M1</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 45873,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11478,
      "choices": [
        {
          "id": 45878,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Luminal A: ER/PR +, Her 2 -, Ki67 high</span></span></span></p>"
        },
        {
          "id": 45879,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Luminal B: ER +, Her 2 -, Ki 67 high</span></span></span></p>"
        },
        {
          "id": 45880,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triple negative: ER/PR -, Her 2 -, Ki 67 high</span></span></span></p>"
        },
        {
          "id": 45881,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Her 2 enriched: ER/PR -, Her 2 +, Ki 67 high</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the mismatch receptor profile of breast cancer:</span></span></span></p>",
      "unique_key": "Q2934648",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621167,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Luminal A: ER/PR +, Her 2 -, Ki67 high</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Luminal A: ER/PR +, Her 2 -, Ki67 high&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Luminal A breast cancers are typically <strong>ER and/or PR positive</strong>, <strong>HER2 negative</strong>, and have a <strong>low Ki-67 index</strong>, which indicates a <strong>lower rate of cell proliferation</strong>. This <strong>subtype</strong> generally has a <strong>better prognosis and is more responsive to hormonal therapy</strong>. Therefore, the presence of a high Ki-67 labeling index in this option is mismatched with the typical profile of Luminal A.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>molecular subtypes of breast cancer</strong> are characterized <strong>based on the presence or absence of hormone receptors</strong> (estrogen and progesterone receptors) and <strong>HER2 status</strong>, as well as proliferation rates, typically indicated by Ki-67 labeling index. Let&#39;s go through each </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Luminal B: ER +, Her 2 -, Ki 67 high.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Luminal B cancers are <strong>ER-positive and tend to have a higher Ki-67 index than Luminal A</strong>, indicating a <strong>higher proliferation rate</strong>. They can be HER2 negative. This option is a correct match for the Luminal B subtype.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Triple Negative: ER, PR -, Her 2 -, Ki 67 high.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triple-negative breast cancers <strong>lack ER, PR, and HER2 expression.</strong> They often have a higher Ki-67 index, which is consistent with their more aggressive behavior. This option correctly describes the Triple Negative subtype.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Her 2 enriched: ER/PR -, Her 2 +, Ki 67 high.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HER2-enriched cancers are <strong>characterized by the absence of hormone receptors</strong> (ER and PR negative) and <strong>overexpression/amplification of HER2</strong>. They often exhibit high Ki-67 levels, which correlates with the aggressive nature of this subtype. This option correctly represents the HER2-enriched subtype.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Luminal A breast cancers&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are typically <strong>ER/PR positive, HER2 negative,</strong> and have a <strong>low Ki-67 index</strong>, indicating <strong>lower proliferation rates</strong>. The presence of a high Ki-67 index in this subtype, as indicated in Option A, is a mismatch.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Along with ER, PR, and Her-2, a proliferation index known as ki-67 index is also used. Ki 67 is a nuclear protein associated with cellular proliferation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Molecular classification of cancers:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/screenshot-2024-03-20-174420.png\" style=\"height:712px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bailey 28<sup>th</sup> Ed. Pg 931, Table 58.4</span></strong></span></span></p>",
      "correct_choice_id": 45878,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11613,
      "choices": [
        {
          "id": 46418,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thyroid antibodies</span></span></span></p>"
        },
        {
          "id": 46419,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">USG neck</span></span></span></p>"
        },
        {
          "id": 46420,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Fine needle aspiration cytology</span></span></span></p>"
        },
        {
          "id": 46421,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Radioactive iodine uptake</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A patient with 3x2 cm nodular thyroid swelling underwent a thyroid profile. Normal T4 and TSH levels were seen. What is the next best step in management?</span></span></span></p>",
      "unique_key": "Q4767807",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621168,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: </span></span></strong><strong><span style=\"font-size:12.0pt\">B. USG neck</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">USG is the next best step in the evaluation of a euthyroid patient with a solitary thyroid nodule. USG helps to classify the risk of the nodule into benign and malignant.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Benign nodules are easily compressible and can be seen to deform by applying pressure with the probe while performing USG. Malignant nodules tend to be hard and firm.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">USG findings of a nodule that are considered suspicious of malignancy are:</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Hypervascularity</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Spiculations</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Infiltrative margins</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Hypoechoic compared to surrounding parenchyma</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:120px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Reference: Bailey and Love:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> edition 27, page 808, 809</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Sabiston textbook of surgery 20<sup>th</sup> edition, page 890</span></span></span></p>",
      "correct_choice_id": 46419,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11619,
      "choices": [
        {
          "id": 46442,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cystic lesion</span></span></span></p>"
        },
        {
          "id": 46443,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Follicular lesion</span></span></span></p>"
        },
        {
          "id": 46444,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lesion suspicious of malignancy</span></span></span></p>"
        },
        {
          "id": 46445,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Non neoplastic lesion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 27 year old female underwent an FNAC for a discrete thyroid swelling. The report showed a Thy2 lesion. What is your inference?</span></span></span></p>",
      "unique_key": "Q1966484",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621169,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans: D. Non neoplastic lesion</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FNAC reporting according to the Royal College of Pathologists UK:</span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/screenshot-2023-04-26-123631_eORTQDr.jpg\" style=\"height:541px; width:800px\" /></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Reference:</span></strong><span style=\"font-size:12.0pt\"> Bailey and Love 27<sup>th</sup> edition, page 805</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sabiston textbook of surgery 2oth edition, page 898</span></span></p>",
      "correct_choice_id": 46445,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11628,
      "choices": [
        {
          "id": 46478,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">80%</span></span></span></p>"
        },
        {
          "id": 46479,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">20%</span></span></span></p>"
        },
        {
          "id": 46480,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">90%</span></span></span></p>"
        },
        {
          "id": 46481,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">10%</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A radionuclide scan done in a patient with a thyroid nodular swelling, shows the following image. </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">How much is the<span style=\"color:black\"> risk of this pathology being benign?</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/screenshot-2023-04-26-123631_zipAvOB.jpg\" style=\"height:887px; width:800px\" /></span></span></span></p>",
      "unique_key": "Q8456133",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621170,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans: A. 80%</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The uptake by the thyroid of a low dose of either radiolabeled iodine (<sup>123</sup>I) or the cheaper technetium (<sup>99m</sup>Tc) will demonstrate the distribution of activity in the whole gland. </span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Routine isotope scanning is unnecessary and inappropriate for distinguishing benign from malignant lesions because the majority (80%) of &lsquo;cold&rsquo; swellings are benign and some (5%) functioning or &lsquo;warm&rsquo; swellings will be malignant. Its principal value is in the toxic patient with a nodule or nodularity of the thyroid. </span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Reference:</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> page 854 Bailey and Love edition 28<sup>th</sup> </span></span></span></p>",
      "correct_choice_id": 46478,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11631,
      "choices": [
        {
          "id": 46490,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Sternal incision is always required to operate.</span></span></span></p>"
        },
        {
          "id": 46491,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Most of the retrosternal goiters can be removed by neck incision</span></span></span></p>"
        },
        {
          "id": 46492,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It receives blood supply from the thoracodorsal artery</span></span></span></p>"
        },
        {
          "id": 46493,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Operated in all patients regardless of symptoms</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Following options are a few statements about retrosternal goiter. Choose the correct statement.</span></span></span></p>",
      "unique_key": "Q2323484",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621171,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: B. Most of the retrosternal goiters can be removed by neck incision</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Most of the retrosternal goiters&nbsp; can be removed by neck incision (transcervical.)</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option A: median sternotomy approach is indicated in:</span></span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Primary mediastinal goitre</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Malignant retrosternal goitre</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Very large retrosternal goiter</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Recurrence in mediastinum for a primary mediastinal goitre whose boundaries or completely within the chest, resection is often achieved through a median sternotomy or thoracotomy to ensure that the vessels supplying the tumour are properly ligated. Removing the tumour through a cervical approach can result in uncontrolled bleeding and is generally avoided.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option C: blood supply to retrosternal goitre is from the thyroid vessel.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option D: surgical removal of the retrosternal goiter is indicated in patients with significant airway compression, in young patients who have symptoms such as dyspnea or dysphagia.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Reference:</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Bailey and Love 27<sup>th</sup> edition, pages 810,811</span></span></span></p>",
      "correct_choice_id": 46491,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11633,
      "choices": [
        {
          "id": 46498,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 24 year old woman with FNAC report of Bethesda category 4</span></span></span></p>"
        },
        {
          "id": 46499,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 60 year old man with FNAC report of Thy2</span></span></span></p>"
        },
        {
          "id": 46500,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 15 year old with recurrence of thyroid cyst</span></span></span></p>"
        },
        {
          "id": 46501,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 66 year old man with positive Pemberton&rsquo;s sign</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P<span style=\"color:black\">atients present in your OPD, with the following reports. To which patient will you least likely advise surgery?</span></span></span></p>",
      "unique_key": "Q6645327",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621172,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: B. A 60 year old man with FNAC report of Thy2</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">FNAC report Thy2 is suggestive of non neoplastic origin and is not an indication for surgery.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Indications for surgical management of thyroid swellings are in the following:</span></span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Neoplasia: FNAC positive Thy3-5 and clinical suspicion</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Age</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Male sex</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Hard texture</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Fixity</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Recurrent laryngeal nerve palsy</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Recurrent cyst</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Lymphadenopathy</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Toxic adenoma</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Pressure symptoms</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Cosmesis </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Patient&rsquo;s wishes</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Reference:</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> bailey and love 27<sup>th</sup> edition, page 810</span></span></span></p>",
      "correct_choice_id": 46499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11638,
      "choices": [
        {
          "id": 46518,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Due to parathyroid gland</span></span></span></p>"
        },
        {
          "id": 46519,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Rough handling of thyroid during surgery</span></span></span></p>"
        },
        {
          "id": 46520,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Infections</span></span></span></p>"
        },
        {
          "id": 46521,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Inadequate patient preparation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Most usual cause of thyroid storm in thyroidectomy is?</span></span></span></p>",
      "unique_key": "Q4536448",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621173,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: D. Inadequate patient preparation</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The usual cause of thyroid storm in thyroidectomy is inadequate patient preparation, before surgery. Patient preparation of operatively involves ensuring a euthyroid state.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Thyroid storm/ thyrotoxic crisis:</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">It is an emergency caused by an acute exacerbation of hyperthyroidism. The precipitating factors include;</span></span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">When a thyrotoxic patient has been inadequately prepared for thyroidectomy.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Abrupt cessation of anti thyroid medications</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Stress like</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Infections</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Thyroid or non thyroid surgery</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Trauma in patients with untreated thyrotoxicosis</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Acute iodine load</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Amiodarone administration</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Exposure to iodinated contrast agents</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Following RAI therapy</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Clinical features:</span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Fever</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Tachycardia</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Altered mental state ( delirium, psychosis, coma)</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">GI symptoms: nausea, vomiting, diarrhoea</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Atrial fibrillation and cardiac failure: most common cause of death.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/screenshot-2023-04-26-123631_JJR1jOY.jpg\" style=\"height:563px; width:800px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Reference:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> bailey and love 27<sup>th</sup> edition page 815</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Schwartz&rsquo;s principles of surgery 10<sup>th</sup> edition, page 1534</span></span></span></p>",
      "correct_choice_id": 46521,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11639,
      "choices": [
        {
          "id": 46522,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Partial resection of each lobe removing the bulk of the gland</span></span></span></p>"
        },
        {
          "id": 46523,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Total resection of lobes on one side, with partial resection of the other side</span></span></span></p>"
        },
        {
          "id": 46524,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Total resection of one lobe with partial resection of three lobes</span></span></span></p>"
        },
        {
          "id": 46525,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Resection of two lobe with the removal of isthmus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The following statement best describes Hartley-Dunhill procedure:</span></span></span></p>",
      "unique_key": "Q9255033",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621174,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: B. Total resection of lobes on one side, with partial resection of the other side</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The Hartley Dunhill procedure involves total lobectomy on the affected side with subtotal resection of the less affected side.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Other thyroid surgeries:</span></span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Lobectomy: all or one thyroid lobe is removed</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Hemithyroidectomy: total lobectomy of one lobe +isthmusectomy</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Subtotal thyroidectomy: 2x subtotal lobectomy (leaving greater than 4g of thyroid tissue on each lobe) + isthmusectomy.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Near total thyroidectomy: total lobectomy but leaving less than 1g tissue adjacent to the RLN at the ligament of Berry on one lobe + isthmusectomy (Hartley-dunhill procedure)</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Total thyroidectomy: 2x total lobectomy + isthmusectomy</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Reference:</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Bailey and Love 27<sup>th</sup> edition, page 807</span></span></span></p>",
      "correct_choice_id": 46523,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11641,
      "choices": [
        {
          "id": 46530,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In the TE groove as it forms one part of the Beahrs triangle</span></span></span></p>"
        },
        {
          "id": 46531,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">At the level of the Berry&rsquo;s ligament as it enters the larynx</span></span></span></p>"
        },
        {
          "id": 46532,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">As the nerve loops around the aorta</span></span></span></p>"
        },
        {
          "id": 46533,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Under the tubercle of Zuckerlandl on the posterolateral position of the gland</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A surgeon is performing a thyroid surgery. Which of the following points poses the highest risk for recurrent laryngeal nerve injury?</span></span></span></p>",
      "unique_key": "Q9361223",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621175,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: B. At the level of the Berry&rsquo;s ligament as it enters the larynx</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Berry&#39;s ligament is formed by posterior condensation of the pretracheal fascia and is attached to the larynx. It has the highest risk for RLN injury.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">RLN is a branch of the vagus nerve. On the left, it recurs over the arch of aorta, and on the right over the subclavian artery.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Beahrs triangle also known as the recurrent laryngeal nerve triangle is formed by the:</span></span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Common carotid artery</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Inferior thyroid arteries</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Recurrent laryngeal nerve</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/picture1_2nXhQUx.png\" style=\"height:751px; width:800px\" /></span></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Reference:</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Bailey and Love 27<sup>th</sup> edition, page 801</span></span></span></p>",
      "correct_choice_id": 46531,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11642,
      "choices": [
        {
          "id": 46534,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Horner’s syndrome</span></p>"
        },
        {
          "id": 46535,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Transient hypocalcemia</span></p>"
        },
        {
          "id": 46536,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Recurrent laryngeal nerve injury</span></p>"
        },
        {
          "id": 46537,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Post op hematoma</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">A 30 year old female underwent a </span><span style=\"font-size:12.0pt;\">retro-esophageal</span><span style=\"color:black;font-size:12.0pt;\"> goitre resection. She was found to have ptosis and loss of hemifacial sweating. What is your diagnosis?</span></p>",
      "unique_key": "Q9274743",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621176,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"background-color:white;color:black;font-size:12.0pt;\"><strong>Ans: A. Horner’s syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">The cervical sympathetic trunk is </span><span style=\"font-size:12.0pt;\">at risk</span><span style=\"color:black;font-size:12.0pt;\"> of injury in invasive thyroid cancers and </span><span style=\"font-size:12.0pt;\">retro-esophageal</span><span style=\"color:black;font-size:12.0pt;\"> goiters and may result in Horner’s syndrome.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Reference:</strong> Schwartz’s principles of surgery 10<sup>th</sup> edition, page 1556</span></p>",
      "correct_choice_id": 46534,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11666,
      "choices": [
        {
          "id": 46630,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Perform a re exploration of the thyroid gland</span></p>"
        },
        {
          "id": 46631,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Call her for a bi annual follow up</span></p>"
        },
        {
          "id": 46632,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">USG guided FNAC</span></p>"
        },
        {
          "id": 46633,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Radioactive iodine ablation</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">A 45 year old woman has come to your clinic for a follow up after she underwent a total thyroidectomy 2 months back, for papillary thyroid carcinoma. On doing a whole body iodine scan, the report suggested a positive iodine scan. How will you proceed further in this case?</span></p>",
      "unique_key": "Q4085249",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621177,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"background-color:white;color:black;font-size:12.0pt;\"><strong>Ans: D. Radioactive iodine ablation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">RAI ablation is undertaken when a whole body iodine scan is positive after a total thyroidectomy, for any differentiated thyroid cancer.</span></li><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">The presence of ang metastatic or residual thyroid tissue after total thyroidectomy can be detected by observing the uptake of RAI in the entire body. To achieve uptake of radioiodine, TSH levels need to be greatly increased.</span></li><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">A positive whole body thyroid scan after total thyroidectomy indicates that there is either a metastatic or residual disease present. These patients will be treated by RAI ablation.</span></li><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">A negative whole body iodine scan after total thyroidectomy indicates that there are no metastases or residual thyroid tissue present. These patients are followed up regularly with USG-neck, serum TG and TSH.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">If the tumour is resistant to RAI, then EBRT(external </span><span style=\"font-size:12.0pt;\">beam</span><span style=\"color:black;font-size:12.0pt;\"> radiotherapy) is done.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>References:</strong></span><span style=\"font-size:12.0pt;\"> </span><span style=\"color:black;font-size:12.0pt;\">Bailey and Love: 27<sup>th</sup> edition, page 819</span></p>",
      "correct_choice_id": 46633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11664,
      "choices": [
        {
          "id": 46622,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pregnant lady with papillary thyroid cancer</span></p>"
        },
        {
          "id": 46623,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Autonomous toxic nodule after 45 years</span></p>"
        },
        {
          "id": 46624,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">In follicular carcinoma of thyroid, after total thyroidectomy</span></p>"
        },
        {
          "id": 46625,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">In primary thyrotoxicosis after 45 years</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Radioactive iodine ablation of thyroid is an absolute contraindication in?</span></p>",
      "unique_key": "Q3183830",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621178,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"background-color:white;color:black;font-size:12.0pt;\"><strong>Ans: A. Pregnant lady with papillary thyroid cancer</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12.0pt;\">It is contraindicated in pregnancy due to exposure of the fetus to radiation.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12.0pt;\"><strong>Therapeutic uses of RAI are:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">In primary thyrotoxicosis after 45 years</span></li><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">In autonomous toxic nodule after 45 years, it is useful as remaining gland will still function adequately after RT</span></li><li><span style=\"color:black;font-size:12.0pt;\">In follicular carcinoma of thyroid, after total thyroidectomy, if there are secondaries elsewhere in the body, as in bones or lungs, then I<sup>131 </sup>is given.</span></li></ul><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12.0pt;\"><strong>Ref</strong>: Bailey 28<sup>th</sup> Ed. Pg 862,870</span></p>",
      "correct_choice_id": 46622,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11660,
      "choices": [
        {
          "id": 46606,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Medullary carcinoma</span></span></span></p>"
        },
        {
          "id": 46607,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Anaplastic carcinoma</span></span></span></p>"
        },
        {
          "id": 46608,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Hurthle cell carcinoma</span></span></span></p>"
        },
        {
          "id": 46609,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thyroid lymphoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">HPE was done on a 50 year old patient </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">with a history<span style=\"color:black\"> of a diffuse enlargement of thyroid gland. Lab studies revealed low T3, T4, high TSH and the presence of anti TPO antibodies. The HPE showed enlarged cells with abundant eosinophilic cytoplasm. Which of the following malignancies is commonly associated with this condition?</span></span></span></p>",
      "unique_key": "Q9592121",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621179,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: D. Thyroid lymphoma</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The case is suggestive of hashimoto&rsquo;s thyroiditis. Thyroid lymphomas are associated in long standing cases. These are usually non-hodgkin lymphomas often associated with long standing Hashimoto&rsquo;s thyroiditis.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">clinical features: </span></span></strong></span></span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Fatigue, 2. Weight gain, 3. Constipation, 4. Dry skin, 5. Hair loss, 6. Muscle and joint pain, 7. Depression, 8. Menstrual irregularities, 9. Enlarged thyroid gland.</span></span></span></span></span></li>\r\n</ol>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Diagnosis:</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Trucut biopsy preferred over FNAC since FNAC cannot characterize lymphomas.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Treatment:</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">R-CHOP regimen of chemotherapy is the first line of management. i.e., Rituximab, Cyclophosphamide, Hydroxydaunorubicin (Adriamycin), oncovin (vincristine), prednisolone.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Chemotherapy and radiotherapy are often sufficient. Total thyroidectomy can be done in recurrent cases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Reference:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> Schwartz&rsquo;s principles of surgery 10<sup>th</sup> edition page 1538</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Bailey and Love 27<sup>th</sup> edition page 821</span></span></span></p>",
      "correct_choice_id": 46609,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11659,
      "choices": [
        {
          "id": 46602,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Prophylactic neck dissection is done.</span></span></span></p>"
        },
        {
          "id": 46603,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Calcium supplementation is given post op</span></span></span></p>"
        },
        {
          "id": 46604,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Hemithyroidectomy is done</span></span></span></p>"
        },
        {
          "id": 46605,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thyroxine is withheld after surgery</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 35 year old patient came to the surgeon with a thyroid swelling </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">for<span style=\"color:black\"> 1 year. O/E the patient appeared euthyroid. Lymphadenopathy was a significant finding. The swelling was 3.5cm in size and was firm and immobile. A biopsy of the swelling showed the following histopathological picture. Choose the incorrect statement regarding management and post-op care.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/screenshot-2023-04-26-123631_tjA8Umq.jpg\" style=\"height:507px; width:800px\" /></span></span></span></p>",
      "unique_key": "Q9109507",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621180,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: C. Hemithyroidectomy is done</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The above picture shows papillary formation with a fibrovascular stalk, characteristic orphan Anne nuclei and psammoma bodies, diagnostic of papillary carcinoma of the thyroid. Though the tumour is less than 4 cm, there is lymphadenopathy and hence total thyroidectomy with central neck dissection should be done.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Calcium supplementation is usually prescribed routinely to all patients after thyroidectomy to prevent symptoms of hypocalcemia.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Patients who are scheduled to receive RAI within 2-3 weeks of surgery may be discharged home without any thyroid hormone replacement. Thyroid hormone withdrawal raises the TSH level which stimulates radio iodine uptake and improves the efficacy of RAI.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Papillary thyroid cancer:</span></span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Most common thyroid cancer</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Most common in iodine sufficient areas, children and in those exposed to ionising radiation.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The mean age of presentation is 3<sup>rd</sup> to 4<sup>th</sup> decade and is more common in women than men. Dysphagia, dysphonia and dyspnea are associated with local invasion.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">It usually presents as a cold nodule on the scan. Histological findings include:</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Branching papillae</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Follicles with fibrovascular stalk</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Psammoma bodies</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Nuclear changes:</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Optically clear: ground glass or Orphan Anne nuclei</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Pseudo-inclusions</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Nuclear grooves</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Lymph node mets are common. Lateral aberrant thyroid denotes a&nbsp; cervical lymph node invaded by papillary carcinoma. The most common sites of metastasis: lung&gt; liver &gt; bone&gt; brain.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Has excellent prognosis </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">with a 10 year<span style=\"color:black\"> survival rate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Reference:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> Schwartz&rsquo;s principles of surgery 10<sup>th</sup> edition page 1647</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Sabiston textbook of surgery 20<sup>th</sup> edition pg 907</span></span></span></p>",
      "correct_choice_id": 46604,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11657,
      "choices": [
        {
          "id": 46594,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Antivirals</span></span></span></p>"
        },
        {
          "id": 46595,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Antibiotics</span></span></span></p>"
        },
        {
          "id": 46596,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">NSAIDs</span></span></span></p>"
        },
        {
          "id": 46597,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Antithyroid drugs</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 40 year old female presented with malaise, fever, painful neck swelling. She had recently recovered from an episode of URTI. Lab reports show elevated ESR, and elevated T4 levels. How will you manage this patient?</span></span></span></p>",
      "unique_key": "Q3124079",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621181,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: C. NSAIDs</span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The given scenario is suggestive of De Quervain&rsquo;s thyroiditis for which NSAIDs is the DOC. Here, T3 and T4 may be raised because of the release of preformed hormones from the destructed follicles.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Dequevrain&rsquo;s thyroiditis (sub acute or viral thyroiditis) is a granulomatous enlargement of the thyroid gland, usually following a viral infection. It is an inflammatory condition and not an infection as the thyroid gland is inherently resistant to infection due to the extensive blood supply and lymphatics, high iodide content and fibrous capsule.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This disease predominantly occurs in women between 30-40 years. The condition is self limiting and management is symptomatic, ie. aspirin and other NSAIDs. Steroids may be indicated in severe painful cases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Reference:</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Bailey and Love&rsquo;s short practice of surgery 27<sup>th</sup> edition, page 822</span></span></span></p>",
      "correct_choice_id": 46596,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11656,
      "choices": [
        {
          "id": 46590,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">No further intervention </span></span></span></p>"
        },
        {
          "id": 46591,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Perform central neck dissection</span></span></span></p>"
        },
        {
          "id": 46592,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Perform RAI ablation</span></span></span></p>"
        },
        {
          "id": 46593,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Perform a total thyroidectomy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A patient presents with a Thy3 lesion on FNAC. He was posted for </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">hemithyroidectomy<span style=\"color:black\">. HPE shows the following findings. What is your next step of management?</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/picture1_6rUC0g5.png\" style=\"height:566px; width:800px\" /></span></span></span></p>",
      "unique_key": "Q8346443",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621182,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: D. Perform a total thyroidectomy</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Capsular invasion seen in image confirms follicular carcinoma, hence total thyroidectomy to be done.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">As FNAC shows Thy3 lesion, which is a follicular neoplasm, the frozen section of the excised specimen has to be evaluated. The presence of vascular invasion confirms follicular carcinoma.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Surgical management of differentiated thyroid cancers (DTCS) are as follows:</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/screenshot-2023-04-26-123631_mRhxAzB.jpg\" style=\"height:607px; width:800px\" /></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Reference: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">schwartz&rsquo;s principles of surgery 11<sup>th</sup> edition page number 1651</span></span></span></span></span></p>",
      "correct_choice_id": 46593,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11653,
      "choices": [
        {
          "id": 46578,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Level V cervical node</span></span></span></p>"
        },
        {
          "id": 46579,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Level VI cervical node</span></span></span></p>"
        },
        {
          "id": 46580,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ectopic thyroid in anterior sternocleidomastoid muscle</span></span></span></span></span></p>"
        },
        {
          "id": 46581,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Mediastinal node</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which of these represents lateral aberrant thyroid?</span></span></span></p>",
      "unique_key": "Q9318887",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621183,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: B. Level VI cervical node</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&ldquo;There is an extensive lymphatic network within and around the gland. Although some lymph channels pass directly to the deep cervical nodes, the subcapsular plexus drains principally to the central compartment </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">juxta thyroid<span style=\"color:black\"> &ndash; &lsquo;Delphian&rsquo; and paratracheal nodes and nodes on the superior and inferior thyroid veins (level VI) &ndash; and from there to the deep cervical (levels II, III, IV and V) and mediastinal groups of nodes (level VII)&rdquo;.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <span style=\"color:black\">Bailey 28<sup>th</sup> Ed. Pg 850.</span></span></span></p>",
      "correct_choice_id": 46579,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15784,
      "choices": [
        {
          "id": 63096,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">Emergency cricothyrotomy&nbsp;</span></span></span></span></span></p>"
        },
        {
          "id": 63097,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Emergency tracheostomy&nbsp;</span></span></span></p>"
        },
        {
          "id": 63098,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Shift to OT and remove sutures of wound&nbsp;</span></span></span></p>"
        },
        {
          "id": 63099,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">Needle thoracotomy in triangle of safety&nbsp;</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">After total thyroidectomy, in post-operative recovery room, patient experienced acute breathlessness and cyanosis. His O2 saturation dropped to 85%. What is the next step?&nbsp;</span></span></span></span></span></p>",
      "unique_key": "Q5652580",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621184,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: C. Shift to OT and remove sutures of wound&nbsp;</span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">&ldquo;Haemorrhage is the most frequent life-threatening complication of thyroidectomy. Around 1 in 50 patients will develop a haematoma, and in almost all cases this will develop in the first 24 hours. If an arterial bleed occurs, the tension in the central compartment pressure can rise until it exceeds venous pressure. Venous oedema of the larynx can then develop and cause airway obstruction, leading to death. </span></span></span></span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">If a haematoma develops, clinical staff should know to remove skin sutures in order to release some pressure and seek senior advice immediately. Endotracheal intubation should be used to secure the airway while the haematoma is evacuated and the bleeding point controlled.&rdquo;&nbsp;</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: </span></span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">Bailey 28<sup>th</sup>&nbsp;Ed. Pg 865.</span></span>&nbsp;</span></span></span></p>",
      "correct_choice_id": 63098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15783,
      "choices": [
        {
          "id": 63092,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Ligation of ITA away from the gland&nbsp;</span></p>"
        },
        {
          "id": 63093,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Ligation of STA away from the gland&nbsp;</span></p>"
        },
        {
          "id": 63094,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Ligation of ITA close to the gland&nbsp;</span></p>"
        },
        {
          "id": 63095,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Ligation of STA close to the gland&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"background-color:white;color:black;font-size:12.0pt;\">Which of these manoeuvres will prevent post op hypoparathyroidism in thyroidectomy (STA= Superior thyroid artery, ITA= Inferior thyroid artery)?&nbsp;&nbsp;</span></p>",
      "unique_key": "Q1720729",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621185,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"background-color:white;color:black;font-size:12.0pt;\"><strong>Ans: C&nbsp;Ligation of ITA close to the gland</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12.0pt;\">Truncal ligation of the inferior thyroid artery away from the gland can lead to hypoparathyroidsm due to ischemia. Both superior and inferior parathyroid glands receive their blood supply from ITA which arises from the subclavian arteries. Hence, during thyroidectomy, only the capsular branches closer to the thyroid gland should be ligated.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12.0pt;\">Sometimes the parathyroid glands may have variable blood supply from thyroid-ima artery.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12.0pt;\"><strong>Reference</strong>: Gray’s anatomy: the anatomical basis of clinical practice , 41<sup>st</sup>&nbsp;edition, page 618&nbsp;</span></p><p><br><span style=\"background-color:white;color:black;font-size:12.0pt;\">Schwartz’s principle of surgery 10<sup>th</sup>&nbsp;edition, pages 1553-1554&nbsp;</span></p>",
      "correct_choice_id": 63094,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15782,
      "choices": [
        {
          "id": 63088,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Wound exploration&nbsp;</span></span></span></span></span></p>"
        },
        {
          "id": 63089,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Indirect laryngoscopy for vocal palsy&nbsp;</span></span></span></p>"
        },
        {
          "id": 63090,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Serum calcium level&nbsp;</span></span></span></p>"
        },
        {
          "id": 63091,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Serum TSH, free T3 and T4 level&nbsp;</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">2 days post total thyroidectomy, patient complains of peri-oral tingling. What would be the next step?&nbsp;</span></span></span></span></span></p>",
      "unique_key": "Q3986023",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621186,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: C. Serum calcium level&nbsp;</span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">&ldquo;This is due to removal of the parathyroid glands or infarction through damage to the parathyroid end arteries; often both factors occur together. Vascular injury is probably far more important than inadvertent removal. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">The incidence of permanent hypoparathyroidism should be less than 1% and most cases present dramatically 2&ndash;5 days after operation; very rarely, the onset is delayed for 2&ndash;3 weeks or a patient with marked hypocalcaemia may be asymptomatic. The complication is limited to total thyroidectomy, as when lobectomy is performed the contralateral parathyroid glands are sufficient to maintain calcium levels. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">In particular, total thyroidectomy with central neck dissection places the parathyroid glands and their vascular supply at great risk and should only be performed when there is evidence of metastatic disease or high risk of occult disease in the regional lymph nodes.&rdquo;&nbsp;</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\">For mild hypocalcemia, oral calcium and severe hypocalcemia, intravenous Calcium gluconate are supplemented.&nbsp;</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:black\">Ref</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:black\">: Bailey 28<sup>th</sup>&nbsp;Ed. Pg. 866.</span></span></span></span></span></span></p>",
      "correct_choice_id": 63090,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11677,
      "choices": [
        {
          "id": 46674,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Local invasion of surrounding structures</span></span></span></p>"
        },
        {
          "id": 46675,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cervical Lymph node enlargement </span></span></span></p>"
        },
        {
          "id": 46676,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Anaplastic thyroid cancer</span></span></span></p>"
        },
        {
          "id": 46677,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Hurthle Cell follicular carcinoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Sudden rapid enlargement of a pre- existent thyroid swelling was noticed in a 75 year old woman. She now has difficulty </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">swallowing<span style=\"color:black\"> and </span>talking<span style=\"color:black\">. What is the probable diagnosis?</span></span></span></p>",
      "unique_key": "Q9266860",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621187,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans: C. Anaplastic thyroid cancer</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anaplastic carcinoma is the most aggressive thyroid carcinoma with a poor prognosis. It usually occurs in elderly women above the age of 65 years and most often causes dysphagia. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Clinical features: </span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Rapidly enlarging neck mass</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Dysphagia</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Cervical tenderness</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">History of untreated DTC</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Hoarseness of voice and tracheal obstruction</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Diagnosis: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">FNAC. </span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Management:</span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">&nbsp;If metastasis is absent: total thyroidectomy + LN dissection</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">If metastasis is&nbsp; present : palliative care with chemotherapy and radiotherapy</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">If tracheal obstruction : </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">isthmusectomy<span style=\"color:black\"> to relieve tracheal obstruction</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Reference:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> Bailey and love 27<sup>th</sup> edition, page 820</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Schwartz&rsquo;s principles of surgery 10<sup>th</sup> edition page 1550</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Sabiston textbook of surgery 20<sup>th</sup> edition pg 910</span></span></span></span></span></p>",
      "correct_choice_id": 46676,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11675,
      "choices": [
        {
          "id": 46666,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Anaplastic carcinoma of thyroid</span></span></span></p>"
        },
        {
          "id": 46667,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Medullary carcinoma of thyroid</span></span></span></p>"
        },
        {
          "id": 46668,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Papillary carcinoma of thyroid</span></span></span></p>"
        },
        {
          "id": 46669,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thyroid lymphomas</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">External low dose neck radiation predisposes to which kind of cancer most commonly?</span></span></span></p>",
      "unique_key": "Q7901580",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621188,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: C. Papillary carcinoma of thyroid.</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">History of low dose RT therapy to the head and neck for acne and tonsillitis and a cold nodule on RAI uptake scan are suggestive of papillary carcinoma.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The great majority of thyroid cancers have no known aetiological factor. The most important identifiable aetiological factor in differentiated thyroid carcinoma (particularly papillary) is irradiation of the thyroid under 5 years of age. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Reference: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Bailey and Love 28<sup>th</sup> Edition: page 867</span></span></span></span></span></p>",
      "correct_choice_id": 46668,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11671,
      "choices": [
        {
          "id": 46650,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It has a much poorer prognosis compared to follicular thyroid cancer</span></span></span></p>"
        },
        {
          "id": 46651,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The investigation of choice for its diagnosis is FNAC</span></span></span></p>"
        },
        {
          "id": 46652,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">They are often bilateral and multifocal</span></span></span></p>"
        },
        {
          "id": 46653,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Total thyroidectomy is the surgery of choice</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which of the following statements is </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">false<span style=\"color:black\"> with respect to the cancer shown in the below histopathological slide?</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/screenshot-2023-04-26-123631_fhf1TGA.jpg\" style=\"height:397px; width:600px\" /></span></span></span></p>",
      "unique_key": "Q8721204",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621189,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: </span></span></strong><strong><span style=\"font-size:12.0pt\">B. &nbsp;The investigation of choice for its diagnosis is FNAC</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The above clinical picture is that of a Hurthle cell follicular carcinoma. Hurthle cell carcinoma is a variant of follicular cell carcinoma.</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">It has a poorer prognosis compared to follicular carcinomas as they are more likely to metastasize.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">They are often bilateral and multifocal.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The HPE slide shows </span></span><span style=\"font-size:12.0pt\">predominance<span style=\"color:black\"> of oxyphil/Hurthle/Askanazy cells containing abundant mitochondria. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">They cannot be diagnosed on FNAC due to capsular and vascular invasion.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Surgical management is as follows:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/screenshot-2023-04-26-123631_2Xcqwsm.jpg\" style=\"height:327px; width:800px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ref</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">: Bailey 28<sup>th</sup> Ed. Pg 868-869</span></span></span></span></p>",
      "correct_choice_id": 46651,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11609,
      "choices": [
        {
          "id": 46402,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lahey&rsquo;s method</span></span></span></p>"
        },
        {
          "id": 46403,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Crile&rsquo;s method</span></span></span></p>"
        },
        {
          "id": 46404,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pizzillo<span style=\"color:black\"> method</span></span></span></p>"
        },
        {
          "id": 46405,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Kocher&rsquo;s method</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A doctor uses this method to palpate the midline swelling in the neck. Choose the correct option.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/picture1_ufYFscg.png\" style=\"height:666px; width:800px\" /></span></span></span></p>",
      "unique_key": "Q5702353",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621190,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: </span></span></strong><strong><span style=\"font-size:12.0pt\">B. Crile&rsquo;s method</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The following image depicts Crile&rsquo;s method of palpation. Here, the patient is asked to swallow, while the examiner palpates the gland with the thumb. This method is sensitive in detecting a slight enlargement of the thyroid gland or small nodules.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Other methods:</span></span></span></span></p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Lahey&rsquo;s method: the lobes of the gland are pushed to one side for palpation. For palpating the left lobe, the examiner should push the lobe laterally </span></span><span style=\"font-size:12.0pt\">with the left<span style=\"color:black\"> hand and the lobe is palpated </span>using the right<span style=\"color:black\"> hand.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Pizillo method: employed only in patients with short necks, usually in obese patients</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Kocher&rsquo;s method: done to </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">demonstrate the pressure<span style=\"color:black\"> effect of the thyroid gland on the trachea or larynx. Lateral compression will result in stridor.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: S. Das A manual on clinical surgery. Pg 378-380</span></span></strong></span></span></p>",
      "correct_choice_id": 46403,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11606,
      "choices": [
        {
          "id": 46390,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thyroglossal tract only</span></span></span></p>"
        },
        {
          "id": 46391,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Central part of hyoid bone and thyroglossal tract </span></span></span></p>"
        },
        {
          "id": 46392,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thyroglossal tract and part of thyroid</span></span></span></p>"
        },
        {
          "id": 46393,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thyroglossal tract and associated cervical lymph nodes</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A child with a midline swelling in the neck, has to undergo a sistrunk procedure. Along with en bloc cystectomy, what other structures will the surgeon resect?</span></span></span></p>",
      "unique_key": "Q1210567",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621191,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Answer: B. Central part of hyoid bone and thyroglossal tract </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sistrunk operation involves en bloc cystectomy with excision of the entire thyroglossal tract till the base of the tongue along with the central hyoid bone.&nbsp; It is the procedure of choice for the surgical management of thyroglossal cysts. Aim of surgery is to prevent recurrence and malignant transformation.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common malignancy in a thyroglossal cyst is papillary carcinoma. In such cases, sistrunk operation with total thyroidectomy is done.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Schwartz&rsquo;s principles of surgery 10<sup>th</sup> edition page no 1522</span></span></p>",
      "correct_choice_id": 46391,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11594,
      "choices": [
        {
          "id": 46342,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oil of evening primrose</span></span></span></p>"
        },
        {
          "id": 46343,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Danazol</span></span></span></p>"
        },
        {
          "id": 46344,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamoxifen</span></span></span></p>"
        },
        {
          "id": 46345,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lumpectomy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of these are components in management of cyclical mastalgia in women suffering from ANDI breast except:</span></span></p>",
      "unique_key": "Q7266795",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621192,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Lumpectomy</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lumpectomy&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>surgical procedure to remove a breast lump</strong> and is <strong>not typically indicated for the management of mastalgia</strong>, which is usually treated medically.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Oil of Evening Primrose:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Evening primrose oil is <strong>rich in gamma-linolenic acid</strong> and is <strong>used as a dietary supplement</strong> to manage the symptoms of <strong>cyclical mastalgia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Danazol:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Danazol is a <strong>synthetic steroid that alters the hormonal milieu and is often used in the treatment of severe mastalgia</strong>. It&#39;s an effective, though less commonly used treatment due to its side effect profile.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Tamoxifen:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamoxifen is a <strong>selective estrogen receptor modulator</strong> used in the <strong>management of breast pain</strong>, particularly when it&#39;s severe or resistant to other treatments.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For <strong>women suffering from cyclical mastalgia due to ANDI</strong> (aberrations of normal development and involution), <strong>management typically includes supportive measures and medications such as evening primrose oil</strong>, <strong>tamoxifen</strong>, or<strong> danazol</strong>. Lumpectomy is not a component of managing cyclical mastalgia as it is a surgical intervention reserved for the removal of lumps with potential or confirmed malignancy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management of Mastalgia: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reassure adequate support</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tight sports brassiere during the day </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Use a VAS breast pain chart to record severity </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Consider medication </span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flax seeds or Oil of evening primrose </span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topical NSAID cream (diclofenac or piroxicam)- Useful in mild to moderate mastalgia </span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Consider systemic medication if pain score &gt;3 on a VAS of 0-10 </span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamoxifen 10&nbsp;mg daily For 3&ndash;6 months </span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Danazol 50&ndash;300&nbsp;mg daily For 3&ndash;6 months </span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Meloxifene 30&nbsp;mg twice For 3&ndash;6 months used in both cyclical a week and non-cyclical mastalgia and for treating nodularity</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LHRH agonist of Short duration: use for 3 months with anti estrogen: recalcitrant pain not relieved by the tamoxifen or raloxifene.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bailey 28<sup>th</sup> E. table 58.2</span></strong></span></span></p>",
      "correct_choice_id": 46345,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11591,
      "choices": [
        {
          "id": 46330,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop taking OCP</span></span></span></p>"
        },
        {
          "id": 46331,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DO mammography annually</span></span></span></p>"
        },
        {
          "id": 46332,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genetic counseling &amp; BRCA testing</span></span></span></p>"
        },
        {
          "id": 46333,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate prophylactic mastectomy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 37-year-old unmarried female, nulliparous having regular sexual intercourse, on OCPs since last 3 years, gives the history that her mother had carcinoma breast at 50 years of age and sister had ovarian cancer at 40 years of age. What will you advise as the next step? </span></span></p>",
      "unique_key": "Q7329512",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621193,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Genetic counseling and BRCA testing</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genetic Counseling &amp; BRCA Testing&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given her <strong>family history of breast</strong> and <strong>ovarian cancer</strong>, <strong>genetic counseling</strong> and <strong>BRCA testing are indicated.</strong> This will help to determine her risk for developing these cancers and guide appropriate surveillance and preventive strategies.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Stop taking OCP:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral contraceptive pills (OCPs) have been <strong>associated with a slightly increased risk of breast cancer</strong>, but they also <strong>offer protective effects against ovarian cancer</strong>. The decision to stop OCPs should be individualized based on a detailed risk assessment.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Do Mammography Annually:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While annual mammography is <strong>important for breast cancer screening</strong>, <strong>starting annual mammograms at 37</strong> without other indications might not be necessary, and it does not address her genetic risk.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Immediate Prophylactic Mastectomy:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prophylactic mastectomy may be <strong>considered for those with a confirmed high genetic risk</strong> (BRCA positive), but it is not the immediate next step before genetic risk is assessed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a patient with a <strong>family history of breast and ovarian cancer</strong>, the <strong>next step is genetic counseling</strong> and <strong>BRCA testing to assess hereditary cancer risk</strong> and guide further preventive measures, rather than immediate prophylactic surgery or alteration of contraceptive practices.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indications for genetic risk evaluation </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An individual at any age with a known pathogenic/likely pathogenic variant in a cancer susceptibility gene within the family </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breast cancer diagnosed age &le;50 years</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TNBC diagnosed age &le;60 years </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Two breast cancer primaries </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breast cancer at any age with one or more relative with breast cancer diagnosed &le;50 years, invasive ovarian cancer, male breast cancer, pancreatic cancer, high-grade or metastatic prostate cancer </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breast cancer at any age with two or more affected relatives </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Male breast cancer</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bailey 28<sup>th</sup> Ed. Summary box 58.5</span></strong></span></span></p>",
      "correct_choice_id": 46332,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11589,
      "choices": [
        {
          "id": 46322,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Imprint cytology</span></span></span></p>"
        },
        {
          "id": 46323,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sentinel LN biopsy </span></span></span></p>"
        },
        {
          "id": 46324,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fine-needle aspiration cytology</span></span></span></p>"
        },
        {
          "id": 46325,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tru Cut biopsy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following histopathological modalities is the best to confirm the diagnosis of breast carcinoma?</span></span></p>",
      "unique_key": "Q8782448",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621194,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Tru Cut biopsy </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tru Cut/core-needle biopsy&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>investigation of choice for confirming the diagnosis of breast carcinoma</strong>. If it is inconclusive, <strong>excisional biopsy can be done</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tru cut needle biopsy:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 14G-16 G needle is used.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It permits the analysis of breast tissue architecture.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The advantages include a low complication rate, minimal scarring, and a lower cost as compared to excisional breast biopsy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A (Imprint Cytology):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This technique involves <strong>pressing a tissue sample onto a glass slide to transfer cells,</strong> which are then <strong>stained and examined under a microscope</strong>. While it can provide rapid results, it is not as definitive as a core-needle biopsy because it does not preserve tissue architecture.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B (Sentinel Lymph Node Biopsy):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This procedure is used to <strong>determine the spread of breast cancer by examining the first lymph node</strong>(s) to which cancer cells are likely to spread from the primary tumor. It is not used for the initial diagnosis of breast cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C (Fine-Needle Aspiration Cytology - FNAC):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FNAC uses a <strong>thin needle to extract cells from a breast lump</strong>. It is <strong>less invasive</strong> than a <strong>core biopsy</strong> and can quickly suggest a diagnosis, but it may not be as definitive, particularly for distinguishing between in situ and invasive carcinomas.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fine-needle aspiration cytology (FNAC) is a cytological investigation done using a 22-30G needle and is not the investigation of choice. FNAC cannot determine if a tumor is invasive or in situ. It is, however, the initial investigation in many cases. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Image-guided biopsy is used only in the case of non-palpable lesions.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Schwartz principle of surgery -9<sup>th</sup> edition page no 529, Bailey 28<sup>th</sup> Ed pg 918.</span></strong></span></span></p>",
      "correct_choice_id": 46325,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11585,
      "choices": [
        {
          "id": 46306,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mammography</span></span></span></p>"
        },
        {
          "id": 46307,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">USG </span></span></span></p>"
        },
        {
          "id": 46308,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRI </span></span></span></p>"
        },
        {
          "id": 46309,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choose the radiographic modality that you will use to assess a patient&rsquo;s breast containing silicone implants:</span></span></p>",
      "unique_key": "Q3422322",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621195,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) MRI </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRI&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>preferred imaging modality for evaluating the integrity of breast implants</strong> and for <strong>assessing the breast tissue in women with implants</strong>. It is more sensitive and provides a detailed image without the interference of the implant material.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Mammography:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>mammography</strong> is the <strong>standard imaging modality for breast cancer screening</strong>, it has limitations in evaluating breasts with silicone implants, as the implants can obscure visualization of the breast tissue.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B (USG):</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ultrasound</strong> may help in <strong>evaluating certain areas of the breast</strong> and <strong>can be useful in distinguishing between fluid-filled cysts and solid masses</strong>, but it does not provide as comprehensive an assessment as MRI, especially in the presence of implants.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D (CT):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Computed tomography</strong> (CT) is <strong>not typically used for routine breast imaging due to its lower sensitivity for detecting small breast cancers</strong> and because it exposes the patient to a higher dose of radiation compared to mammography.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Magnetic resonance imaging&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(MRI) is the <strong>best imaging modality</strong> for the <strong>breasts of women with implants.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRI of the breast is also used in:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Screening of individuals&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">with a <strong>positive family history/high risk of breast cancer</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assessing loco-regional spread (multifocality and multicentricity) of carcinoma</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Differentiating scar form recurrence in women who have received breast conservation therapy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bailey and love&rsquo;s short practice of surgery -28th edition page no 916-917</span></strong></span></span></p>",
      "correct_choice_id": 46308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11520,
      "choices": [
        {
          "id": 46046,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Annual mammogram</span></span></span></p>"
        },
        {
          "id": 46047,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Regular checking of LFT once in 6 months</span></span></span></p>"
        },
        {
          "id": 46048,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow-up with tumor markers once in 6 months</span></span></span></p>"
        },
        {
          "id": 46049,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Yearly bone scans</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 38-year-old woman underwent treatment for breast cancer of 1.2 x 1 cm with positive axillary nodes. She completed radiotherapy and chemotherapy and is now receiving tamoxifen. Which investigation will you use for follow-up in the patient?</span></span></p>",
      "unique_key": "Q1428720",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621196,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Annual mammogram</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>follow-up of breast cancer</strong> patients after <strong>treatment is crucial for early detection of recurrence</strong> and <strong>monitoring for any complications of treatment</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Annual Mammogram</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> an <strong>annual mammogram is the standard follow-up investigation</strong> for <strong>breast cancer patients</strong>. It is <strong>used to monitor the treated breast</strong> and the <strong>contralateral breast</strong> for any new findings <strong>suggestive of recurrence or a new primary breast cancer</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Regular Checking of Liver Function Tests (LFTs) Once in 6 Months.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Routine liver function tests</strong> are <strong>not standard in the follow-up of breast cancer</strong> patients unless there are specific clinical indications or if the patient is experiencing symptoms suggestive of metastatic disease or complications related to systemic therapies.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Follow-up with Tumor Markers Once in 6 Months&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>use of tumor markers for routine follow-up in asymptomatic patients</strong> <strong>after primary treatment</strong> for <strong>breast cancer</strong> is not recommended. They have not been shown to provide a survival benefit in this setting.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Yearly Bone Scans</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Routine bone scans</strong> are <strong>not indicated for follow-up in asymptomatic breast cancer patients after primary treatment</strong>. They are reserved for patients with symptoms or clinical findings that suggest bone metastasis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow-up of patients after treatment of breast cancer&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">consists of <strong>routine physical examination once in 3 months for a year and annual mammogram.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mammography&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>only imaging modality</strong> necessary for <strong>follow-up after breast cancer surgery</strong>. There is currently no role for tumor markers, serum investigations, or any other imaging studies like bone scan in follow-up.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guidelines for follow-up:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physical examination:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For the first 2 years: once every 3 to 6 months</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For 3-5 years: once every 6 to 12 months after 5 years: Annually</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mammography:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Initially, 6 months after surgery</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thereafter, annually.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bailey &amp; Love&rsquo;s short practice of surgery 27<sup>th</sup> edition Pg 879</span></strong></span></span></p>",
      "correct_choice_id": 46046,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11535,
      "choices": [
        {
          "id": 46106,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A history of smoking&nbsp; </span></span></span></p>"
        },
        {
          "id": 46107,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A history of recent breastfeeding </span></span></span></p>"
        },
        {
          "id": 46108,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A history of hormonal contraceptive use </span></span></span></p>"
        },
        {
          "id": 46109,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A history of recent trauma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 38-year-old female presents with a chief complaint of persistent breast discomfort. On examination, there is localized tenderness, erythema, and a palpable breast lump. Nipple shows slit like retraction with fish mouth appearance. Which of the following findings is most likely risk factor in this patient?</span></span></p>",
      "unique_key": "Q6814266",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621197,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) A history of smoking</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given scenario of <strong>tenderness, lump and slit like nipple retraction</strong> is suggestive of <strong>duct ectasia/chronic periductal mastitis</strong> which is commonly associated with <strong>smoking</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Breast feeding&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>linked to mastitis or breast abscess</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Hormonal contraceptive&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are associated with <strong>breast carcinoma</strong>, although the risk is small</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Recent trauma&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">or <strong>hematoma</strong> may lead to <strong>traumatic fat necrosis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Duct ectasia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, characterized by the <strong>dilation of lactiferous ducts and periductal inflammation</strong>, is the <strong>most common cause of greenish nipple discharge</strong> in the <strong>non-lactating breast</strong>, particularly in <strong>women above 50 years of age</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Duct ectasia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(periductal mastitis) involves <strong>dilatation of multiple ducts</strong>, which is often associated with <strong>periductal inflammation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common <strong>age group affected</strong>: <strong>above 50 years</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common <strong>presenting feature</strong>: <strong>nipple discharge</strong> </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/screenshot-2024-03-20-190546.png\" style=\"height:437px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient presents with <strong>central non-cyclical pain, pus discharge from the nipple and a subareolar tender mass</strong>/ abscess or mammary duct fistula. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The examination reveals a tender, firm subareolar lump or abscess, purulent nipple discharge, thickened tender major milk ducts and a <strong>transverse slit-like nipple retraction looking like a fish&rsquo;s mouth</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasonography&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">shows <strong>thickened major milk ducts</strong> with surrounding inflammation or abscess. A lump should be biopsied under ultrasound guidance to confirm the diagnosis.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The treatment for duct ectasia is <strong>Hadfield&rsquo;s operation</strong>, which refers to the cone excision of the major duct system or sub areolar resection. <strong>All lactiferous ducts under the nipple are removed.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This procedure is performed when the duct of origin for the nipple bleeding is uncertain or when there is bleeding or discharge from multiple ducts.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If a <strong>single duct is involved</strong>, then <strong>microdochectomy is the treatment of choice</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>most common cause of blood-stained discharge</strong> from a <strong>single duct is duct papilloma</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>most common cause of blood-stained discharge</strong> from <strong>multiple ducts</strong> is duct carcinoma.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>most common cause of serous discharge</strong> from the <strong>breast is fibrocystic disease</strong> of the breast.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Single duct single breast serous or sanguineous&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(4S) nipple discharge is considered pathological</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bailey and love&rsquo;s short practice of surgery -27<sup>th</sup> edition page no 864, 867. 28<sup>th</sup> Ed. Pg 927.</span></strong></span></span></p>",
      "correct_choice_id": 46106,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16138,
      "choices": [
        {
          "id": 64512,
          "text": "<p><span style=\"font-size:12pt;\">Felt at rest</span></p>"
        },
        {
          "id": 64513,
          "text": "<p><span style=\"font-size:12pt;\">Most commonly felt in the calf muscles</span></p>"
        },
        {
          "id": 64514,
          "text": "<p><span style=\"font-size:12pt;\">Day to day distance is variable</span></p>"
        },
        {
          "id": 64515,
          "text": "<p><span style=\"font-size:12pt;\">Relived after getting out of bed</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 45-year-old chronic smoker is diagnosed with peripheral vascular disease. Identify the true statement about intermittent claudication:&nbsp;(NEET PG 2020)</span></p>",
      "unique_key": "Q9925642",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621198,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Most commonly felt in the calf muscles</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Most commonly felt in the calf muscles:<strong> </strong>Correct. Intermittent claudication most commonly affects the calf muscles because the disease often affects the arteries supplying the lower limbs, usually the superficial femoral artery (70% of cases). Patients describe it as a cramping or aching sensation that occurs with walking or exertion and is relieved with rest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Felt at rest: </strong>Incorrect. Intermittent claudication is typically brought on by physical activity and relieved by rest. It occurs due to inadequate blood flow to the muscles during exertion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Day to day distance is variable: </strong>Incorrect. While the severity of peripheral artery disease can change over time (especially without treatment), typically, the distance a person can walk before symptoms begin is fairly consistent, especially in the early stages of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Relieved after getting out of bed: </strong>Incorrect. Intermittent claudication pain is typically relieved after a few minutes of rest and doesn't specifically correlate with getting out of bed. The pain usually occurs during physical activities, such as walking, and subsides with rest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Intermittent claudication is most commonly felt in the calf muscles due to the high prevalence of peripheral artery disease affecting the arteries that supply the lower limbs. This condition is typically brought on by physical activity and relieved by rest.</span></p>",
      "correct_choice_id": 64513,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24475,
      "choices": [
        {
          "id": 97861,
          "text": "<p><span style=\"font-size:14.0pt;\">On doppler, “monophasic flow” implies normal flow</span></p>"
        },
        {
          "id": 97862,
          "text": "<p><span style=\"font-size:14.0pt;\">Rest pain is seen at ABPI &lt; 0.5</span></p>"
        },
        {
          "id": 97863,
          "text": "<p><span style=\"font-size:14.0pt;\">0.1 decrease in ABPI leads 10% increase in mortality</span></p>"
        },
        {
          "id": 97864,
          "text": "<p><span style=\"font-size:14.0pt;\">Toe pressure is more reliable of ischemia in patients with diabetes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the incorrect statement about peripheral vascular disease:</span></p>",
      "unique_key": "Q3208702",
      "question_audio": null,
      "question_video": null,
      "map_id": 18621199,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) On doppler, “monophasic flow” implies normal flow</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>peripheral vascular disease (PVD)</strong>, understanding Doppler findings and assessment measures is crucial:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>On Doppler, “monophasic flow” implies normal flow</strong>: <strong>Incorrect</strong>. Normal arterial flow in the peripheral arteries is <strong>triphasic</strong>, indicating good vascular compliance and normal resistance. <strong>Monophasic flow</strong> is abnormal and indicates significant arterial disease with poor distal blood flow.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Rest pain is seen at ABPI &lt; 0.5</strong>: <strong>Correct</strong>. Rest pain in PVD patients typically occurs when the <strong>ankle-brachial pressure index (ABPI)</strong> is less than 0.5, indicating severe ischemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. 0.1 decrease in ABPI leads to a 10% increase in mortality</strong>: <strong>Correct</strong>. A decrease in ABPI is associated with increased cardiovascular mortality risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Toe pressure is more reliable for detecting ischemia in patients with diabetes</strong>: <strong>Correct</strong>. In diabetic patients, calcification of the arteries can make ABPI measurements unreliable. <strong>Toe pressure</strong> or the <strong>toe-brachial pressure index</strong> is often more accurate in assessing the severity of ischemia in these patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Monophasic flow</strong> on Doppler is an indicator of <strong>significant arterial disease</strong>, not normal flow. Additionally, understand the importance of using <strong>toe pressure</strong> in diabetic patients for a more accurate assessment of ischemia, as ABPI can be unreliable due to calcified arteries.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>ARTERIAL DOPPLER</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Duplex scan= USG (B mode) + Doppler</span></li><li><span style=\"font-size:14.0pt;\">Normal flow- Triphasic-&gt; bi-&gt; Mono-&gt; absent</span></li><li><span style=\"font-size:14.0pt;\">ABPI- &lt;0.9 (occlusion), &lt;0.5 (rest pain), &lt;0.3 (CLI)</span></li><li><span style=\"font-size:14.0pt;\">0.1 fall in ABPI-&gt; 10% increase in CV event</span></li><li><span style=\"font-size:14.0pt;\">TBI &lt; 0.6 in diabetes is more significant marker</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/08/29.jpg\" alt=\"\" width=\"500\" height=\"316\"></span></p>",
      "correct_choice_id": 97861,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}